I wonder if anyone have update on Sequel performance and how it compares to RSII.
-
-
There was a PacBio user group meeting in Baltimore (in last two weeks) where an update was given about Sequel performance (based on a note I saw from a FAS). Apparently that information has not been published but if someone on SeqAnswers was in attendance then they may be able to comment.Comment
-
Thanks GenoMax. The system release was announced almost 8 months ago and I thought there might be some installed machines in production or in validation phase where some operators might have been trained and seen some real data to compare with Sequel announced specs or RSII.Comment
-
We don't have any data, but we have a (growing) list of service providers who have installed the Sequel platform: http://ngs.is/PBSequelOriginally posted by nucacidhunter View PostComment
-
They do not seem to offer any service on the Sequel.Comment
-
This is a big mystery. There are reports of machines in the wild (at least with close collaborators of PacBio) but no one seems to have released real data as yet. There is nothing EBI-ENA at this time either.Originally posted by nucacidhunter View PostComment
-
We have two of them, but they are still being qualified.Comment
-
A few service providers had told me they expect to start providing Sequel services in June. I expect we should see some data soon?
At the UGM pacbio did mention they expect to start shipping their new chip at the end of the month along with a new loading protocol. So maybe service providers are waiting for that? I'm sure Sequel owners here would have a better idea of whats going on though.Comment
-
Hi Brian,
is this with your previous or the new employer?
Thanks!
A Sequel talk from April: https://www.youtube.com/watch?v=hmx3HGs9imsOriginally posted by Brian Bushnell View PostLast edited by luc; 06-20-2016, 09:46 AM.Comment
-
Comment
-
Google's loss but good for usOriginally posted by Brian Bushnell View Post
Both! I left Google and came back to JGI. So, it's at JGI.
We will have to count on you @Brian to see some unbiased eval of Sequel data once you get your hands on some.Comment
-
Ditto!Originally posted by GenoMax View PostGoogle's loss but good for us
( The following errors occurred with your submission:
The message you have entered is too short. Please lengthen your message to at least 10 characters.)Comment
-
Does anyone have information on how the Sequel data compares to the RSII? And when service providers will begin offering Sequel services?Comment
-
It is hard to tell but the description for this dataset seems to include verbiage about Sequel (not sure why the submitters would include that if this was a RSII): http://www.ebi.ac.uk/ena/data/view/SRX1684788
Most likely a red herring but who knows. Raw bax/bas.h5 files are available in case someone is curious (http://trace.ncbi.nlm.nih.gov/Traces...run=SRR3342814 under Download tab).Last edited by GenoMax; 07-22-2016, 05:21 AM.Comment
-
HiOriginally posted by Brian Bushnell View Post
We are facing some issues with our new sequal system installed recently. Pacbio team is unable suggest loading clear loading concentration of different sized library.
The out put varies with each run and the maximum we got till now is 3.2gb for 2 kb library.
For the higher sized library the runs will yield 0.2-0.9gb per SMRT.We are unable to find out where the problem lies.Also after completing each run the volume of libraries pickedup from the sample well is not consistent.
Pac bio suggestion for the loading conc is 50-60pM for any size library.
There is another suggestion from PacBio is that system and smrtlink need to be restarted every 24 days, Is it true?
Please helpComment
-
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...Today, 09:55 AM -
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing...
Comment